Innovation in the commercialization of new medicines: the 4 pillars from the Marketing Authorization to Market Access
This is a Workshop in which the speakers are representative of the four pillars: evaluation and authorization of the medicinal product, represented by the The Spanish Agency of Medicines and Medical Devices (AEMPS) with the Spanish representative from the Committee of Advanced Therapies (CAT), the Hospital Drug Product Access through the Pharmacotherapeutic Guidelines with a representative of the Spanish Society of Hospital Pharmacy (SEFH), the Market Access from the pharmaceutical industry, with a Responsible of a Department of Pharmacoeconomics in BMS and the Regulatory Affairs with a Qualified Person and RA Director from Mundipharma.
The moderator of the table is one of the leaders in the world of Pharma Market Access, Health Economics and Outcomes Reseach/Pricing and Reimbursement, with extended teaching experience:
-Jose Manuel Rodriguez Barrios. Health Economics, Pricing and Market Access Strategy Europe Director, Daiichi Sankyo Europe.
KEYWORDS & TOPICS
Presentador – Moderador:
Speaker: José Manuel Rodriguez Barrios
Institution: Economics, Pricing and Market Access Strategy Director Europe, Daiichi Sankyo Europe.
Title: First of the 4 pillars: Innovation in Marketing Authorizations.
Speaker: Sol Ruiz Antúnez
Institution: Head of Sector of Biotechnology and Advanced Therapies at the Spanish Medicines Agency- CAT member and and a co-opted member of the CHMP (Committee for Human Medicinal Products) at European Medicines Agency.
Title: Second pillar from Marketing Authorization to Market Access: evidence generation from HEOR.
Speaker: Paloma González
Institution: Strategic account & Business Development Lead – Hologic, Inc.
Title: Pricing and Market Access Strategy from Pharma industry: the third pillar.
Speaker: Mª José Sancho González
Institution: QP and Regulatory Affairs Director – Mundipharma.
Title: The fourth pillar from Marketing Authorization to Market Access: the hospital approach and the pharmacotherapeutics guide system.
Speaker: Mª Dolores Fraga Fuentes
Institution: Coordinator at GRUPO GENESIS from SEFH).
Names: Raquel Carnero Gómez
Institution: University of Salamanca, Spain.